Hjem › Endokrine sygdomme › New York
Endokrine sygdomme kliniske forsøg i New York
4 studier for Endokrine sygdomme søger deltagere på steder i New York.
Byer i New York
Officiel studietekst (engelsk)
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
- Ascendis Pharma Investigational Site, Lake Success
RekruttererFase 3
Alder 2 til 17 · Alle køn · Opdateret 30. sep. 2026 · NCT07221851A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism
- Ascendis Pharma Investigational Site, New York
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07081997A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Weill Cornell Medicine - Comprehensive Weight Control Center, New York
- Rochester Clinical Research, LLC, Rochester
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07595549Rare and Atypical Diabetes Network
- SUNY Downstate Health Sciences University, Brooklyn
- Columbia University, New York
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 14. aug. 2025 · NCT05544266Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.